Further, it is still not clear why FGF21 administration tends to improve metabolic endpoints, yet FGF21 levels are paradoxically increased with metabolic conditions such as obesity, type 2 diabetes, and cardiovascular disease. Here, FGF21 is linked to type 2 diabetes mellitus.